Imaging Chemicals Market Report 2026

The imaging chemicals market size has grown strongly in recent years. It will grow from $27.93 billion in 2025 to $29.93 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growth of packaging and label printing, expansion of medical imaging diagnostics, rising use of chemical developers, established demand in textile printing, availability of conventional imaging chemicals.

The imaging chemicals market size is expected to see strong growth in the next few years. It will grow to $38.73 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing adoption of digital printing technologies, rising demand for sustainable inks and toners, expansion of healthcare imaging applications, growing investments in specialty chemical innovation, increasing regulatory focus on low-voc formulations. Major trends in the forecast period include increasing shift toward digital imaging chemicals, rising demand for high-resolution printing inks, growing use in medical diagnostic imaging, expansion of eco-friendly imaging formulations, enhanced performance of specialty toners.

The increasing prevalence of chronic diseases is expected to drive the growth of the imaging chemicals market. Chronic diseases, or non-communicable diseases (NCDs), are long-term conditions characterized by persistence and prolonged impact. Imaging chemicals are critical in diagnosing, monitoring, and managing these diseases, serving as contrast agents or tracers in various imaging modalities to help healthcare professionals visualize internal structures, detect abnormalities, and evaluate disease progression. For instance, in July 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government health statistics agency, chronic conditions accounted for 78% of the fatal burden, an increase from previous years. Therefore, the increasing prevalence of chronic diseases is driving the growth of the imaging chemicals market.

Major companies in the imaging chemicals market are focusing on next-generation solutions, such as advanced gadolinium-based contrast agents (GBCAs), to provide safer, higher-resolution, and more efficient diagnostic imaging. These advanced agents offer greater relaxivity, require lower dosing, and reduce safety concerns related to gadolinium exposure while delivering clearer MRI results. For example, in February 2023, Guerbet Group, a France-based pharmaceutical and medical imaging company, launched Elucirem (gadopiclenol) injection. This next-generation GBCA provides the highest relaxivity among MRI contrast agents, is suitable for adults and children aged 2 years and above, and requires only half the gadolinium dose of traditional non-specific GBCAs. Elucirem enables precise visualization of lesions with abnormal vascularity across the central nervous system and throughout the body, including head and neck, chest, abdomen, pelvis, and musculoskeletal regions.

In October 2023, FUJIFILM Corporation, a Japan-based provider of photographic, semiconductor, and electronic materials solutions, acquired the electronic chemicals business (formerly CMC Materials KMG Corporation) from Entegris, Inc. for US $700 million. This acquisition strengthened FUJIFILM’s footprint in high-purity process chemicals for imaging, lithography, and semiconductor production, enhancing its technological capabilities and global supply chain reach. CMC Materials KMG Corporation was a U.S.-based provider of high-purity process and electronic chemicals used in wafer etching, cleaning, and other critical semiconductor manufacturing processes.

Major companies operating in the imaging chemicals market are Eastman Kodak Company, Agfa-Gevaert NV, Altana AG, BASF SE, Clariant Chemical Company, DIC Corporation, Dow Chemical Company, Flint Group S.A., FUJIFILM Holdings Corporation, Hubergroup Deutschland GmbH, Kao Corporation, Kodak Alaris Inc., Qingdao Scienoc Chemical Co., Sakata Inx Corp., Siegwerk Druckfarben AG & Co. KGaA, T&K TOKA Corporation, Toyo Ink SC Holdings Co. Ltd., Wikoff Color Corporation, Evonik Industries AG, Merck Co. & KGaA.

Asia-Pacific was the largest region in the imaging chemicals market in 2025. The regions covered in the imaging chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the imaging chemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The imaging chemicals market consists of sales of binders, carriers, pigments, and additives used for imaging purposes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.